Our Blog

Keep up to date with our latest conversations, discussions and stories – together we can transform clinical cancer care

ASCO2021 Highlights – Focus on Liquid Biopsy

ASCO2021 Highlights – Focus on Liquid Biopsy

Event expiration date display - 28 Jun 2021

Dr Mike Nahorski who recently joined Inivata as Director, Clinical and Scientific Alliances summarizes the key liquid biopsy highlights at ASCO2021. read more

AACR Annual Meeting 2021 – An overview

AACR Annual Meeting 2021 – An overview

Event expiration date display - 13 MAY 2021

Greg Jones our Sr Director, Medical Affairs provides an overview of the growing evidence for ctDNA changing how we detect residual disease and recurrence read more

Motivated by a meaningful purpose: Tim Forshew, Co-founder and Head of Science and Innovation, Inivata

Motivated by a meaningful purpose: Tim Forshew, Co-founder and Head of Science and Innovation, Inivata

Event expiration date display - 26 APR 2021

Tim talks us through the founding of Inivata and how Nitzan Rosenfeld inspired him to join the team. read more

Product Development from the eyes of an R&D Scientist

Product Development from the eyes of an R&D Scientist

Event expiration date display - 23 APR 2021

Creative and bold individuals make up Inivata. Garima Sharma shares her insights into RaDaR development and how the team have worked together to build an industry-leading liquid biopsy test. read more

LBx Summit 2021 review and thoughts

LBx Summit 2021 review and thoughts

Event expiration date display - 23 FEB 2021

Yanin Naiyachit, Product Manager – Liquid Biopsy Applications here at Inivata, shares his thoughts and key take-aways from the recent LBx Summit 2021. read more

Alan Schafer our new CTO discusses the potential of personalized liquid biopsy in clinical trial development and recruitment

Alan Schafer our new CTO discusses the potential of personalized liquid biopsy in clinical trial development and recruitment

Event expiration date display - 11 NOV 2020

Find out more about the potential of personalized liquid biopsy in clinical trial development and recruitment read more

“Liquid biopsy: a key piece in the diagnostic jigsaw puzzle” by Peter Collins, Chief Business Officer, Inivata

“Liquid biopsy: a key piece in the diagnostic jigsaw puzzle” by Peter Collins, Chief Business Officer, Inivata

Event expiration date display - 11 NOV 2020

We recently welcomed Peter Collins to Inivata as our new CBO, find out more here read more

Sarah Perrey DeGeare in our Lab Operations team talks about what it’s like to be part of #TeamInivata

Sarah Perrey DeGeare in our Lab Operations team talks about what it’s like to be part of #TeamInivata

Event expiration date display - 09 NOV 2020

Find out what it is like to be part of our team. read more

The start of Lung Cancer Awareness Month 2020

The start of Lung Cancer Awareness Month 2020

Event expiration date display - 01 NOV 2020

Today marks the start of Lung Cancer Awareness Month, a critical point in time for all those working on any aspect of this devastating disease to stop, think and remind ourselves why we’re doing ... read more

Jenni Westoby joined our Bioinformatics Team eight months ago and is really enjoying being part of the team.

Jenni Westoby joined our Bioinformatics Team eight months ago and is really enjoying being part of the team.

Event expiration date display - 21 JUL 2020

Find out more about her first few months with us. read more

AACR 2020 Summary: Demonstrating a sensitive and specific personalized assay to detect  residual disease and recurrence

AACR 2020 Summary: Demonstrating a sensitive and specific personalized assay to detect residual disease and recurrence

Event expiration date display - 07 JUL 2020

This year’s annual meeting of the American Association for Cancer Research (AACR) was converted into an entirely virtual experience focused on clinical data as a result of the COVID-19 pandemic. ... read more

Sophie Hackinger in our bioinformatics team discusses the reasons she joined Inivata – I wanted to build products that would have a direct impact on patients’ lives.

Sophie Hackinger in our bioinformatics team discusses the reasons she joined Inivata – I wanted to build products that would have a direct impact on patients’ lives.

Event expiration date display - 20 APR 2020

I started out with an undergraduate degree in biomedical sciences, which was more wet lab focused. What really fascinated me about human biology was how the combination of multiple genetic and ... read more

The development of a highly sensitive test for detecting residual disease and recurrence in cancer patients

The development of a highly sensitive test for detecting residual disease and recurrence in cancer patients

Event expiration date display - 21 JUL 2020

As cells die in our body, they release DNA into our blood stream. This cell free DNA (cfDNA) can come from many sources, including healthy cells such as white blood cells. In individuals with ... read more

Anna Farne, Senior Software Developer at Inivata tells us more about how her role in software development is helping transforming the lives of cancer patients around the world.

Anna Farne, Senior Software Developer at Inivata tells us more about how her role in software development is helping transforming the lives of cancer patients around the world.

Event expiration date display - 7 APR 2020

During my first role working as a lab technician I became interested in IT and how it fits into a science and research environment. There were nice software tools for data analysis, LIMS systems ... read more

Tim Forshew, Co-founder and Head of Science and Innovation at Inivata shares his thoughts on a recent publication from groups at Dana-Farber, Broad Institute and Boston University that demonstrate the value of personalized assays for detecting ctDNA with high sensitivity.

Tim Forshew, Co-founder and Head of Science and Innovation at Inivata shares his thoughts on a recent publication from groups at Dana-Farber, Broad Institute and Boston University that demonstrate the value of personalized assays for detecting ctDNA with high sensitivity.

Event expiration date display - 1 APR 2020

Thoughts on Parsons et al 2020 – a new study on the value of personalized ctDNA assays for residual disease and recurrence detection read more

Warren Emmett, Computational Genomics Team Lead at Inivata talks about how his role in bioinformatics is helping lung cancer patients.

Warren Emmett, Computational Genomics Team Lead at Inivata talks about how his role in bioinformatics is helping lung cancer patients.

Event expiration date display - 04 MAR 2020

I started out with an undergrad in Human Genetics and after doing a tutorial on the BLAST algorithm I fell in love with bioinformatics, and the potential it held for changing biology. After ... read more

The critical importance of sensitivity and how inivata’s technology is expanding the reach of liquid biopsy into new clinical and pharmaceutical applications.

The critical importance of sensitivity and how inivata’s technology is expanding the reach of liquid biopsy into new clinical and pharmaceutical applications.

Event expiration date display - 28 JAN 2020

Antony Newton, VP Business Development, talks about the critical importance of sensitivity and how Inivata’s technology is expanding the reach of liquid biopsy into new clinical and ... read more

Pioneering and focused on making a difference to cancer management – liquid biopsy.

Pioneering and focused on making a difference to cancer management – liquid biopsy.

Event expiration date display - 13 NOV 2019

Liquid biopsy offers the potential to transform the way physicians manage cancer and deliver significant benefits to patients by guiding and personalizing treatment, monitoring response and ... read more

A personal passion for innovation and to make a difference to cancer care.

A personal passion for innovation and to make a difference to cancer care.

Event expiration date display - 31 OCT 2019

A personal passion for innovation and to make a difference to cancer care. Nitzan Rosenfeld, CSO and Co-founder, Inivata talks about the personal story behind his scientific career and his path ... read more

Our Technology

Our Solutions

Latest News

LinkedIn tracking code Twitter tracking code